StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
SRNE stock opened at $0.01 on Friday. The business’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.02. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.35.
About Sorrento Therapeutics
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Survey: Top 175 Fittest Retirement Locations in America
- What Are Dividend Challengers?
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is a Low P/E Ratio and What Does it Tell Investors?
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.